Announcement OrsoBio, a leading clinical-level biopharmaceutical company working towards the development of related metabolic disorders and obesity treatments, have showcased the presentation of new preclinical and clinical data at ObesityWeek® 2025 held in Atlanta, Ga, on November 4-7. The com...
Announcement Avant Technologies Inc., a leading Nevada-based corporation and SGAustria Pte. Ltd., a known Singapore biotechnology company, have formed a groundbreaking alliance and signed a license agreement to bring revolutionary positive changes and advancement in diabetes treatment via encapsul...
Announcement The Association for Diagnostics and Laboratory Medicine (ADLM) has introduced a smart expert-proven guidance on coagulation testing in patients on blood thinners who have a high chance of disrupting these tests. By supporting laboratory medicine professionals and clinicians to map the...
Announcement SimplyTest® has signed a partnership agreement with Evexia Diagnostics, a leading provider of diagnostic laboratory services for unified and functional medicine. With this partnership deal, the two SimplyTests’ focused examinations, 4-point cortisol and SimplyTest PERIO, are...
Announcement The United Parcel Service (UPS), a leading logistics, supply chain and shipping management company, a known American multinational operating across 200 countries and territories, has acquired Andlauer Healthcare Group Inc. (AHG), a popular North American supply chain management compan...
Announcement Evaxion A/S, a leading clinical-level TechBio company, expert in establishing AI-Immunology™-powered vaccines, extended its R&D portfolio with EVX-04, an AI-framed precision cancer vaccine candidate. The company will carry out clinical development of EVX-04, recently been inv...
Announcement The leading United Therapeutics Corporation has completed its first clinical xenotransplantation in its EXPAND study, using UKidney™ in patients with end-stage renal disease (ESRD). At NYU Langone Health, this successful transplant procedure was performed. The UKidney is an inves...
Announcement Estrella Immunopharma, Inc., a leading clinical-level biopharmaceutical company establishing CD19 and CD22-focused ARTEMIS® T-cell therapies to provide treatment to autoimmune and cancer diseases, declared the completion of its second dose associate in the Phase 1 portion of its S...
Announcement Kisumu Governor Anyang’ Nyong’o has revealed the Kisumu County Wellness Screening Protocol/ FAITH MATETE, promising the wellness screening to be an important part of Kisumu’s health management system. This screening will cover routine checks for diabetes, cancer and ...
Announcement IntoCell Inc., a leading biotechnology company establishing linker technologies and next-generation payload for antibody-drug conjugates (ADCs) and Xcellon Biologics, a known US contract development and manufacturing organisation (CDMO), an excellence holder in critical biologics and ...
